Preprints.org
Real-World EHR Signals from a Cohort of Blinded Incretin Trial Participants Motivate Novel Indication Opportunities
Preprint: cohort study of 761 peopleInterventions
Abstract
Understanding organ-specific effects of multi-agonist metabolic therapies beyond weight loss remains challenging, particularly while randomized clinical trials are ongoing and treatment allocation remains blinded.
The paper
Preprints.org, 3 Sep 2026, CC BY, Preprint, not peer-reviewed
